1. Home
  2. PRCT vs CHX Comparison

PRCT vs CHX Comparison

Compare PRCT & CHX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • PRCT
  • CHX
  • Stock Information
  • Founded
  • PRCT 2009
  • CHX 1882
  • Country
  • PRCT United States
  • CHX United States
  • Employees
  • PRCT N/A
  • CHX N/A
  • Industry
  • PRCT Medical Specialities
  • CHX Industrial Machinery/Components
  • Sector
  • PRCT Health Care
  • CHX Industrials
  • Exchange
  • PRCT Nasdaq
  • CHX Nasdaq
  • Market Cap
  • PRCT 5.3B
  • CHX 5.2B
  • IPO Year
  • PRCT 2021
  • CHX N/A
  • Fundamental
  • Price
  • PRCT $81.17
  • CHX $25.79
  • Analyst Decision
  • PRCT Strong Buy
  • CHX Buy
  • Analyst Count
  • PRCT 7
  • CHX 4
  • Target Price
  • PRCT $97.86
  • CHX $39.00
  • AVG Volume (30 Days)
  • PRCT 592.2K
  • CHX 1.9M
  • Earning Date
  • PRCT 10-28-2024
  • CHX 02-03-2025
  • Dividend Yield
  • PRCT N/A
  • CHX 1.47%
  • EPS Growth
  • PRCT N/A
  • CHX 7.15
  • EPS
  • PRCT N/A
  • CHX 1.62
  • Revenue
  • PRCT $199,843,000.00
  • CHX $3,665,501,000.00
  • Revenue This Year
  • PRCT $67.07
  • CHX N/A
  • Revenue Next Year
  • PRCT $40.64
  • CHX $3.98
  • P/E Ratio
  • PRCT N/A
  • CHX $15.92
  • Revenue Growth
  • PRCT 71.71
  • CHX N/A
  • 52 Week Low
  • PRCT $39.48
  • CHX $25.46
  • 52 Week High
  • PRCT $103.81
  • CHX $39.95
  • Technical
  • Relative Strength Index (RSI)
  • PRCT 33.77
  • CHX 22.21
  • Support Level
  • PRCT $79.30
  • CHX $28.66
  • Resistance Level
  • PRCT $92.92
  • CHX $29.69
  • Average True Range (ATR)
  • PRCT 4.06
  • CHX 0.78
  • MACD
  • PRCT -1.87
  • CHX -0.43
  • Stochastic Oscillator
  • PRCT 9.21
  • CHX 5.55

About PRCT PROCEPT BioRobotics Corporation

PROCEPT BioRobotics Corp is a surgical robotics company focused on advancing patient care by developing transformative solutions in urology. It develops, manufactures, and sells the AquaBeam Robotic System,, image-guided, surgical robotic system for use in minimally invasive urologic surgery, with an initial focus on treating benign prostatic hyperplasia, or BPH. The company's assets are based in the United States. Its revenue is generated from sales of the AquaBeam Robotic System and the accompanying single-use disposable handpieces.

About CHX ChampionX Corporation

ChampionX provides chemical solutions and equipment for onshore and offshore oil and gas production. Its engineering expertise spans the well lifecycle, but the firm maintains a particular focus on the production phase. Key offerings include artificial lift services and drilling technologies, specializing in polycrystalline diamond cutter inserts. ChampionX was formed after Apergy acquired its chemical technologies business from Ecolab in 2020.

Share on Social Networks: